Connors M - Search Results

1

Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables.

Doria-Rose NA, Klein RM, Daniels MG, O'Dell S, Nason M, Lapedes A, Bhattacharya T, Migueles SA, Wyatt RT, Korber BT, Mascola JR, Connors M. Doria-Rose NA, et al. Among authors: connors m. J Virol. 2010 Feb;84(3):1631-6. doi: 10.1128/JVI.01482-09. Epub 2009 Nov 18. J Virol. 2010. PMID: 19923174 Free PMC article.

2

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.

Connors M, Kulkarni AB, Firestone CY, Holmes KL, Morse HC 3rd, Sotnikov AV, Murphy BR. Connors M, et al. J Virol. 1992 Dec;66(12):7444-51. doi: 10.1128/JVI.66.12.7444-7451.1992. J Virol. 1992. PMID: 1433525 Free PMC article.

3

Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.

Connors M, Kulkarni AB, Collins PL, Firestone CY, Holmes KL, Morse HC 3rd, Murphy BR. Connors M, et al. J Virol. 1992 Feb;66(2):1277-81. doi: 10.1128/JVI.66.2.1277-1281.1992. J Virol. 1992. PMID: 1731105 Free PMC article.

4

Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived.

Connors M, Collins PL, Firestone CY, Murphy BR. Connors M, et al. J Virol. 1991 Mar;65(3):1634-7. doi: 10.1128/JVI.65.3.1634-1637.1991. J Virol. 1991. PMID: 1995956 Free PMC article.

5

A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.

Connors M, Crowe JE Jr, Firestone CY, Murphy BR, Collins PL. Connors M, et al. Virology. 1995 Apr 20;208(2):478-84. doi: 10.1006/viro.1995.1178. Virology. 1995. PMID: 7747420 Free article.

6

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC 3rd, Murphy BR. Connors M, et al. J Virol. 1994 Aug;68(8):5321-5. doi: 10.1128/JVI.68.8.5321-5325.1994. J Virol. 1994. PMID: 8035532 Free PMC article.

7

The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.

Kulkarni AB, Connors M, Firestone CY, Morse HC 3rd, Murphy BR. Kulkarni AB, et al. Among authors: connors m. J Virol. 1993 Feb;67(2):1044-9. doi: 10.1128/JVI.67.2.1044-1049.1993. J Virol. 1993. PMID: 8419638 Free PMC article.

8

Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.

Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. Matano T, et al. Among authors: connors m. J Virol. 1998 Jan;72(1):164-9. doi: 10.1128/JVI.72.1.164-169.1998. J Virol. 1998. PMID: 9420212 Free PMC article.

9

Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.

Gea-Banacloche JC, Weiskopf EE, Hallahan C, López Bernaldo de Quirós JC, Flanigan M, Mican JM, Falloon J, Baseler M, Stevens R, Lane HC, Connors M. Gea-Banacloche JC, et al. Among authors: connors m. J Infect Dis. 1998 Mar;177(3):579-85. doi: 10.1086/514233. J Infect Dis. 1998. PMID: 9498435

10

Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.

Lee KH, Wang E, Nielsen MB, Wunderlich J, Migueles S, Connors M, Steinberg SM, Rosenberg SA, Marincola FM. Lee KH, et al. Among authors: connors m. J Immunol. 1999 Dec 1;163(11):6292-300. J Immunol. 1999. PMID: 10570323 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters